Invivyd (IVVD) Assets (2020 - 2025)
Invivyd (IVVD) reported Assets of $276.9 million for Q4 2025, up 113.78% on a YoY basis from $129.5 million in Q4 2024, and up 98.97% quarter-over-quarter from $139.2 million in Q3 2025.
Invivyd (IVVD) Assets (2020 - 2025) Analysis & Trends
Invivyd has reported Assets for 6 years, with the latest figure at $276.9 million in Q4 2025.
- For the quarter ending Q4 2025, Assets rose 113.78% year-over-year to $276.9 million; the trailing twelve-month figure through Dec 2025 stood at $276.9 million (up 113.78% YoY), and the FY2025 full-year result was $276.9 million, up 113.78% from the prior year.
- Assets for Q4 2025 stood at $276.9 million, up from $139.2 million in the prior quarter.
- The five-year high for Assets was $686.3 million in Q3 2021, with the low at $89.1 million in Q2 2025.
- Historically, Assets has averaged $316.7 million across 5 years, with a median of $276.9 million in 2025.
- Annual changes were most pronounced in 2021 — Assets jumped 428.27% — and 2025, when it plunged 51.85%.
- Invivyd's Assets stood at $620.1 million in 2021, then sank by 38.21% to $383.2 million in 2022, then plunged by 40.19% to $229.2 million in 2023, then sank by 43.49% to $129.5 million in 2024, then soared by 113.78% to $276.9 million in 2025.
- The last three Assets figures came in at $276.9 million (Q4 2025), $139.2 million (Q3 2025), and $89.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 276.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 276.88 Mn |
| Sep 30, 2025 | 139.16 Mn |
| Jun 30, 2025 | 89.14 Mn |
| Mar 31, 2025 | 103.74 Mn |
| Dec 31, 2024 | 129.52 Mn |
| Sep 30, 2024 | 161.92 Mn |
| Jun 30, 2024 | 177.35 Mn |
| Mar 31, 2024 | 215.47 Mn |
| Dec 31, 2023 | 229.18 Mn |
| Sep 30, 2023 | 274.92 Mn |
| Jun 30, 2023 | 315.41 Mn |
| Mar 31, 2023 | 350.56 Mn |
| Dec 31, 2022 | 383.17 Mn |
| Sep 30, 2022 | 424.75 Mn |
| Jun 30, 2022 | 484.61 Mn |
| Mar 31, 2022 | 556.27 Mn |
| Dec 31, 2021 | 620.09 Mn |
| Sep 30, 2021 | 686.27 Mn |
| Jun 30, 2021 | 397.99 Mn |
| Dec 31, 2020 | 117.38 Mn |